University of Queensland

Researcher in a medical lab
#Acute inflammatory conditions #Curlew Bio #Start-ups #University of Queensland

UQ biotech start-up will target a novel immunological pathway

A new start-up aimed at discovering and developing anti-inflammatory disease medicines has been formed by The University of Queensland’s commercialisation arm UniQuest and global biotech company Molecule to Medicine (MTM).  Curlew Bio will leverage expertise from the Queensland Emory and Drug Discovery Initiative (QEDDI) and research developed… Read More

#News #Start-up Zone

Melanoma or skin cancer
#Immunotherapy #Oncology #Skin cancer #University of Queensland

Cancer immunotherapy reduces skin cancers by 65%

University of Queensland researchers have discovered that immunotherapy, when used to treat people with advanced cancers, also helps reduce sunspots and skin cancers by at least 65%.  Over 12 months, researchers monitored 23 patients receiving immunotherapy for unrelated cancers and found the treatment also targeted cancerous and… Read More

#Cancer Research #News

Stomach pain
#Chronic pain #Irritable Bowel Syndrome #Painkillers #Peptides #University of Queensland

Highly promising new oral approach to abdominal pain

University of Queensland (UQ) researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that is based on the peptide hormone oxytocin. The team changed the chemical structure of oxytocin to make it gut-stable after earlier work revealed the hormone could treat… Read More

#News #Trending News

Professor Glenn King working in the lab with a funnel web spider. Credit The University of Queensland
#Clinical trial #Heart attack #Heart disease #Medical Research Future Fund #University of Queensland

Spider venom heart drug moves to human clinical trials

A project to develop a drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF). Professor Glenn King from the University of Queensland’s (UQ) Institute for Molecular Bioscience… Read More

#News

Vaccine production
#Cancer vaccine #mRNA #mRNA-based vaccines #Oncology #Personalised medicine #University of Queensland

Personalised cancer vaccines to be produced at Queensland lab

A new facility at The University of Queensland, Australia, will provide researchers with cancer vaccines tailored to individual patients. The lab at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) will bring together the equipment and expertise to enable the design, manufacture and delivery of new… Read More

#News

Petri dish used for bacterial research
#Bacteria #Endothelial dysfunction #Preclinical investigations #Sepsis #University of Queensland

New drug could prevent sepsis-related organ failure

A new drug could prevent sepsis-related organ failure and death by restoring the health of a patient’s blood vessels. Researchers from The University of Queensland and the Queensland Children’s Hospital (QCH) have successfully tested the first-in-class drug in mice. Dr Mark Coulthard from UQ… Read More

#News

Genomics
#Funding #Genetics / genomics #Snow Medical Research Foundation #University of Queensland

$8 million awarded to landmark genetic research project

Landmark genetic research could allow doctors to accurately predict whether a patient is at risk of developing common diseases, decades before any symptoms would become evident. Snow Medical Research Foundation has awarded University of Queensland (UQ) researchers $8 million to dramatically advance the use of genomics… Read More

#News

Covid-19 vaccine
#Covid-19 #Immunology / Virology & Vaccines #University of Queensland

Successful clinical trial for re-engineered Covid vaccine 

The University of Queensland’s re-engineered clamp platform has produced a vaccine that is equally safe and virus-neutralising as an approved Covid vaccine considered among the best in its class. The pivotal proof-of-concept testing clears the way to progress the Clamp2 technology in a range of research programmes.  … Read More

#Covid-19 #News

Assoc Prof Tim Mercer and researcher Dae Jong Han, UQ
#Australia #Bioproduction #mRNA #Sanofi #TriLink BioTechnologies #United States #University of Queensland

As mRNA demand surges, Australia and US launch new facilities

As demand for mRNA continues to surge, two new facilities have been launched to boost production in Australia and the US. Work is underway at The University of Queensland’s (UQ) BASE facility which has become Australia’s leading provider of mRNA for research and pilot studies since… Read More

#News

Cancer metastasis
#Cancer drug targets #Cancer research #Drug resistance #Oncology #University of Queensland

Novel inhibitors could become new anticancer therapeutics

University of Queensland (UQ) researchers have identified a novel drug target with the potential to overcome drug resistance and prevent tumour regrowth in cancer patients. The newly identified molecule is not currently a target for treatment, opening the potential for drug development. “Drug resistance… Read More

#Cancer Research #News

Antibiotics
#AMR #Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Immunology / Virology & Vaccines #University of Queensland

Global crisis of antibiotic resistance is “inevitable”

A report by University of Queensland (UQ) researchers has warned a global crisis of antibiotic resistance is inevitable, despite promising developments in new antibiotics. The Centre for Superbug Solutions at UQ’s Institute for Molecular Bioscience has monitored the clinical pipeline for more than a decade, with… Read More

#Editor's Choice #News

Cone snails
#Drug development #Drug discovery #University of Queensland

Cone snail venom discovery opens up new leads for drugs

Researchers have reared deadly cone snails in a laboratory aquarium for the first time, uncovering new venoms for drug development. Professor Richard Lewis, Dr Aymeric Rogalski and Dr Himaya Siddhihalu Wickrama Hewage from University of Queensland’s (UQ) Institute for Molecular Bioscience study venoms as therapeutics, and… Read More

#News

Vaccine production
#Emory University #Immunology / Virology & Vaccines #Pandemic prevention #Partnership #University of Queensland

Brisbane-Atlanta partnership focuses on pandemic response

The University of Queensland (UQ), Australia, and Emory University in Atlanta, US, have committed to scaling up their collaboration to focus on pandemic preparedness and regional disease prevention. UQ Vice-Chancellor Professor Deborah Terry said the Brisbane-Atlanta partnership will bring together world-class researchers to accelerate the development… Read More

#News

Petri dish used for bacterial research
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Bacteria #Sepsis #University of Queensland

Australian sepsis study to power new antibiotic discoveries

University of Queensland (UQ) researchers have led a national study on the four main bacteria that cause sepsis, providing new targets for developing antibiotics. Professor Mark Walker and Professor Mark Schembri from UQ’s Institute for Molecular Bioscience, along with Dr Andre Mu from the University of… Read More

#Editor's Choice #News

Neurons in Parkinson's disease
#Genetics / genomics #Neurodegenerative disorders #Neurology #Neuroscience #Parkinson's #University of Queensland

Focus on autophagy could lead to more effective Parkinson’s drugs

Researchers have identified that a gene associated with an increased risk of Parkinson’s Disease also contributes to a build-up of cell debris in the brain. Dr Adekunle Bademosi from The Queensland Brain Institute said the discovery could change the focus of Parkinson’s Disease treatment. Without the… Read More

#News